| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |